Compare Stocks → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:MSADYNASDAQ:TIL Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMSADYMS&AD Insurance Group$17.69-2.3%$17.29$10.64▼$20.06$28.45B0.44249,217 shs22,719 shsTILInstil Bio$10.40-2.9%$11.41$6.07▼$14.00$67.60M1.2426,362 shs21,035 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMSADYMS&AD Insurance Group+1.12%+7.83%+5.17%+33.46%+68.00%TILInstil Bio0.00%+0.09%-5.02%-9.40%-16.52%Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMSADYMS&AD Insurance Group1.6677 of 5 stars0.03.02.50.00.00.03.1TILInstil Bio2.399 of 5 stars3.33.00.00.01.23.30.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMSADYMS&AD Insurance GroupN/AN/AN/AN/ATILInstil Bio2.67Moderate Buy$36.00246.15% UpsideCurrent Analyst RatingsLatest TIL and MSADY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/12/2024TILInstil BioJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold3/25/2024TILInstil BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$18.00(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMSADYMS&AD Insurance Group$38.87B0.73$1.20 per share14.73$14.07 per share1.26TILInstil BioN/AN/AN/AN/A$34.72 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMSADYMS&AD Insurance Group$1.20B$1.5811.2011.56N/A5.71%9.47%1.32%N/ATILInstil Bio-$156.09M-$23.99N/AN/AN/AN/A-58.49%-41.58%5/9/2024 (Estimated)Latest TIL and MSADY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/21/2024Q4 2023TILInstil BioN/A-$1.99-$1.99-$1.99N/AN/A2/14/2024Q3 2024MSADYMS&AD Insurance GroupN/A$0.8267+$0.8267$1.24N/A$8.93 billionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMSADYMS&AD Insurance Group$0.372.09%N/A23.42%N/ATILInstil BioN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMSADYMS&AD Insurance Group0.180.28N/ATILInstil Bio0.3615.2315.22OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMSADYMS&AD Insurance Group0.02%TILInstil Bio60.56%Insider OwnershipCompanyInsider OwnershipMSADYMS&AD Insurance GroupN/ATILInstil Bio54.70%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableMSADYMS&AD Insurance Group38,5841.61 billionN/ANot OptionableTILInstil Bio496.50 million2.95 millionOptionableTIL and MSADY HeadlinesSourceHeadlineThis actor once saw father saved murder accused, qualified for Olympics, then became Bollywood's top villain, died at...msn.com - April 21 at 9:58 AMSustainability through global collaborationdailypioneer.com - April 19 at 7:54 PMInstil Bio (TIL) Price Target Decreased by 23.15% to 28.22msn.com - April 17 at 12:21 PMJefferies cuts Instil Bio to hold, cites drug discontinuationmsn.com - April 12 at 1:45 PMLearning from nature, investing in people and ownership culture can future-proof the insight functionresearch-live.com - March 29 at 7:34 AMWhat Makes Instil Bio (TIL) a New Buy Stockzacks.com - March 27 at 1:01 PMInstil Bio Non-GAAP EPS of -$1.26 beats by $2.14seekingalpha.com - March 22 at 10:31 AMInstil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - March 21 at 5:00 PMUK Treasury to overhaul crypto regulations to strengthen AML measuresforbesindia.com - March 14 at 7:37 AMA Very Private School — Charles Spencer’s privileged but painful educationft.com - March 12 at 9:18 AMJon Cruddas: ‘Labour has to rediscover its moral purpose’theguardian.com - March 11 at 2:59 PMJunglee Poker launches Apne Type Ke Log campaign featuring Anil Kapoorfinancialexpress.com - February 24 at 7:23 PMInstil Bio Stock (NASDAQ:TIL) Dividends: History, Yield and Datesbenzinga.com - February 24 at 12:50 AMTIL therapies: the impact on cancer researchlabiotech.eu - February 22 at 2:43 PMBehind the new kind of cell therapy that just won FDA approvalbiopharmadive.com - February 22 at 8:26 AMAlexei Navalny death latest: Putin brings new criminal case against critic’s brother as mother pleads for bodysg.yahoo.com - February 21 at 3:33 PMAlexei Navalny death latest: X restores wife Yulia’s account as Putin brings new case against critic’s brotherindependent.co.uk - February 20 at 11:59 PMHow RSS textbooks are reshaping Indian history and science under Modimsn.com - February 19 at 9:49 AMInstil Bio Inc.thestreet.com - February 16 at 4:33 AMBoeing in ‘last chance saloon’, Emirates boss saysmsn.com - February 5 at 1:41 AMAuto industry stakeholders react to Interim Budget 2024financialexpress.com - February 5 at 1:41 AMInterim Budget 2024: On path to a brighter and more prosperous Indiaeconomictimes.indiatimes.com - February 2 at 7:52 AMPrezident Markon’s New Singles Round-up (Okvsho, Ivan Llanes, EDKUB, Sonoras Mil, Nina Camillo, Arthur Melo and more)soundsandcolours.com - January 31 at 1:44 AMAmber Ray, Rapudo's Baby Africanah Lands Lucrative Products Ambassadorial Job at 8 Monthstuko.co.ke - January 31 at 1:44 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsMS&AD Insurance GroupOTCMKTS:MSADYMS&AD Insurance Group Holdings, Inc., an insurance holding company, provides insurance and financial services worldwide. The company offers domestic non-life insurance; life insurance; international business; financial services; and provides risk-related services. The company was formerly known as Mitsui Sumitomo Insurance Group Holdings, Inc. and changed its name to MS&AD Insurance Group Holdings, Inc. in April 2010. MS&AD Insurance Group Holdings, Inc. was founded in 1918 and is headquartered in Tokyo, Japan.Instil BioNASDAQ:TILInstil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its lead product is ITIL-306, a Co-Stimulatory Antigen Receptor molecule to recognize folate receptor alpha, a tumor-associated antigen that is expressed on various solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
